Ua ʻae ʻo FDA i ka mea hana mua no ka hoʻohana ʻana i ka insulin automated no Kākau like 2 Diabetes ke kūlana.
Ma hope o ka hoʻonui ʻia ʻana o ka ʻenehana Insulet SmartAdjust (kahi interoperable glycemic controller) i hōʻike ʻia no ka hoʻokele kikokiko i 1 diabetes. I kēia manawa, e hōʻike ʻia kēia ʻenehana dosing insulin Automated a loaʻa no ka mālama ʻana Kākau like 2 Diabetes pū kekahi.
Hoʻokumu ʻia kēia ʻae ʻia e FDA ma nā ʻike o kahi hoʻokolohua lapaʻau e pili ana i ka hoʻohana ʻana i ka ʻenehana Insulet SmartAdjust e nā poʻe me Kūkulu i ka maʻi maʻamauʻo 2 ma ka insulin therapy. Ua ʻike ʻia ka haʻawina he palekana ka ʻenehana a hoʻomaikaʻi i ke kō koko koko o nā mea komo.
ʻO ka ʻenehana Insulet SmartAdjust, kahi mea hoʻoponopono glycemic automated interoperable he lako polokalamu e hoʻoponopono ʻakomi i ka hāʻawi ʻana i ka insulin i ke kanaka me ka maʻi maʻi maʻi ma o ka hoʻopili ʻana i kahi mea hoʻokele-enabled insulin pump (ACE pump) a me ka integrated continuous glucose monitor (iCGM).
Kūkulu i ka maʻi maʻamauʻo 2 ʻAʻole pane maikaʻi ke kūlana i loko o nā kānaka he nui i ka hoʻokele lāʻau ʻole a me ka mālama ʻana me nā papa anti-diabetic. Pono kēlā poʻe e hoʻokele ponoʻī iā lākou iho i ka insulin i hoʻokahi a ʻoi aku paha i ka lā me ka hoʻohana ʻana i ka inikini a i ʻole ka peni insulin a i ʻole ka paila no ka mālama ʻana i ke kiʻekiʻe o ke kō koko i loko o ka palena palekana. Pono kēia i ka nānā pinepine ʻana i ko lākou pae koko koko no ka hopena maikaʻi loa. ʻO ka mea hana Insulin Dosing Device kahi koho kūpono no kēlā poʻe e hiki ke hoʻomaikaʻi i ka maikaʻi o ke ola.
***
Sources:
- Hoʻokuʻu ʻia ka nūhou FDA - Hoʻomaʻemaʻe ʻo FDA i ka hāmeʻa mua e hiki ai ke hoʻohana i ka Dosing Insulin Automated no nā poʻe me ka maʻi maʻi type 2. Hoʻopuka ʻia 26 ʻAukake 2024. Loaʻa ma https://www.fda.gov/news-events/press-announcements/fda-clears-first-device-enable-automated-insulin-dosing-individuals-type-2-diabetes
***
